United States· US:87047-7852_453d0158-979d-12a6-e063-6294a90afe7f
CYKLX
A articaine product containing articaine hydrochloride, registered in United States by American Genomics, LLC. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Articaine is registered in 2 of 19 countries.
Countries holding a registration under ATC N01BB08 (articaine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Articaine · ATC N01BB08
2 / 19 countries
- Germany
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ARTICAINE HYDROCHLORIDE
- Manufacturer
- American Genomics, LLC
- Country
- United States (US)
- ATC code
- N01BB08
- ATC class
- Articaine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 5, 2026
Packs & prices · 4
- ndc1187047-7852-1
- ndc1187047-7852-2
- ndc11870477852110 POUCH in 1 CARTON (87047-7852-1) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .4 mL in 1 VIAL, SINGLE-DOSE
- ndc1187047785222 POUCH in 1 CARTON (87047-7852-2) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .4 mL in 1 VIAL, SINGLE-DOSE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for articaine.
Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Articaine · interactions on record
22 records
- 21 moderate
- 1 minor
Most severe, free to view
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- LidocaineC05AD01moderate
- TetracaineC05AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Articaine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Ultracain, Ultracain D
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad573fbf-15f0-4caa-8fa0-58e4d7df1ebe GET /v1/drugs/ad573fbf-15f0-4caa-8fa0-58e4d7df1ebe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "80",
"substance": "ARTICAINE HYDROCHLORIDE",
"productndc": "87047-7852",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA218643",
"marketing_category": "NDA"
}See everything about articaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.